Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Jasirwan COM
Hepatocellular carcinoma (HCC) is the second leading cause of cancer death worldwide. It is the most common primary liver cancer with very poor prognosis and outcome. The incidence is much higher in men and stands as third most common cancer among men and seventh in women. Eastern and South-Eastern Asia have the highest incidence with the age-standardized ratio (ASR) of 31.9 and 22.2 per 100.000 respectively. A study in Indonesia by Mulyana investigated that HCC patients’ survival in Cipto Mangunkusumo National General Hospital was very low with only 4.8 months of median survival and 24.1% one-year survival rate. After fifteen years, a recent study in Indonesia showed no improvement in the survival of HCC patients with 29.4% one- year survival rate.
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infection are the primary cause of HCC, while hepatitis B is more common in Asia and developing countries Moreover, the endemicity of hepatitis B in Indonesia is intermediate to high and varied between region ranging from 4.7 to 11.2%